CPR Invest - GEAR Emerging - A EUR - Acc ISIN : LU1811398467

CPR Invest - GEAR Emerging - A EUR - Acc
Asset class: Equities
YTD
As of 05/10/2026
32.12%
Risk IndicatorThe level of risk of the fund mainly reflects the risk of the market in which the fund is invested and, as the case may be, the leveraging strategy or inverse performance of the index. The capital initially invested does not benefit from any guarantee. The current level of risk does not indicate the future level of risk and may change over time. The lowest risk level is not equal to a risk-free investment.
1234567
Lower Risk
Higher Risk
The risk indicator assumes you keep the product according to the holding period.
NAV
As of 07/10/2026
€192.93
SFDR ClassificationSustainable Finance Disclosure Regulation
Art. 8
Fund AUM
As of 07/10/2026
€60.69M
“The fund invests in emerging market equities and seeks to outperform the MSCI Emerging Market index over the long term – at least 5 years. The final portfolio includes around a hundred emerging market stocks from all business sectors and with all sizes of market capitalisation. The investment process involves adapting the stock-picking method to market conditions.”
 

NAVs

NAV from 10/11/2018 to 10/07/2026
Select period
Created with Highcharts 11.4.8CPR Invest - GEAR Emerging - A EUR - AccJan '19Jul '19Jan '20Jul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25Jul '25Jan '26Jul '2675100125150175200225

Performance

Change in NAV in base 100
Returns under control and temporarily unavailable for this fund

Portfolio Analysis

Repartition 09/30/2026
Sector allocationGeographical breakdown (Source: Amundi)Main Lines in Portfolio (Source: Amundi)Currency
Created with Highcharts 11.4.8Values43.38​43.3818.86​18.867.30​7.306.58​6.585.75​5.755.02​5.024.29​4.293.73​3.731.92​1.921.47​1.470.99​0.9943.81​43.8119.36​19.367.40​7.405.90​5.906.32​6.325.75​5.752.59​2.592.69​2.693.40​3.400.95​0.951.85​1.85PortfolioBenchmark0246810121416182022242628303234363840424446Information TechnologyFinancialsConsumer DiscretionaryCommunication ServicesIndustrialsMaterialsConsumer StaplesHealth CareEnergyReal EstateUtilitiesHighcharts.com

Management commentary

Effective date: 30/09/2026Performance
In September 2026, the MSCI Emerging Markets Index posted a performance of +1.69%, thus outperforming the MSCI World Index, which rose by +1.05%. The regional indices of the main emerging countries mostly moved lower. Among the strong performers, Taiwan recorded the best performance at +6.48%, followed by Brazil and South Korea at +5.49% and +5.36% respectively. Poland also advanced by +3.58%. Conversely, South Africa and Turkey suffered the largest declines, at -6.83% and -6.78%. Chile, Indonesia, the Czech Republic, Hungary, India, Mexico, the Philippines, and Thailand also posted negative performances ranging from -1.12% to -5.45%. China ended the month at -2.40%. Performances are expressed in euros.

Key events of the month
Despite accumulating headwinds, such as developed market yields at historic levels, rising oil prices, and a strengthening dollar, the performance of emerging markets remained relatively stable, supported by the artificial intelligence sector. A global rebound in AI-related trade enabled Taiwan and South Korea to outperform the MSCI Emerging Markets Index. The resilience in the technology sector is explained by confirmation of a persistent hardware shortage, likely to worsen until 2027, despite growing concerns about increased regulation of the most advanced AI models. On the macroeconomic front, the yield on ten-year US Treasuries rose by 53 basis points to reach 5.29%, while global developed market yields also increased by 34 basis points. The Fed raised its key rate by 25 basis points at the September meeting and indicated that another hike this year would be appropriate.

Summary of main positions for the month
In September 2026, the fund’s performance stood at +1.21%, compared to +1.69% for the benchmark index.
From a factor perspective, the Alpha Blend factor had a slightly negative impact with a contribution of around -0.04%, while the Defensive Alpha factor showed a neutral contribution at +0.01%. Analysis of the sources of relative performance reveals a positive sector effect, driven by healthcare and consumer staples, but negative in utilities and energy. The country effect is negative, despite a good contribution from South Africa and Taiwan, offset by Brazil and Mexico. The market capitalization size effect is positive.
Among the stocks, ASPEED Technology (overweight, +19%), Mediatek (overweight, +27.8%), Taishin Financial Holdings (overweight, +10.9%), and ASE Technology Holding (overweight, +22.7%) were positive contributors to relative performance. Conversely, Taiwan Semiconductor Manufacturing (underweight), King Slide Works (underweight), Tata Consultancy Services (overweight, -11.9%), and RHB Bank (overweight, -11.1%) detracted from performance.

Outlook for the following month
Market outlook for the end of 2026 anticipates a more inflationary and geopolitically fragile environment, without widespread financial risk. Rising tensions in the Middle East between the United States and Iran have pushed up oil prices, reinforcing inflation and central bank caution. Markets have absorbed previous tensions on liquidity, spreads, and security prices returning close to normal. Monetary policies remain restrictive with high rates, as the Fed, ECB, and Bank of Japan continue to normalize or further raise rates. Inflation remains above targets, especially in the United States and Europe, where the risk of a gas shortage weighs on growth. Bond yields remain high and macroeconomic volatility is intense. Investment remains moderately risk-friendly, favoring equities, particularly in the United States, Japan, and resilient European segments, as well as investment grade credit and convertibles. Emerging markets are approached selectively with overweighting of certain countries and caution on the dollar and euro. The rise in spending related to artificial intelligence supports investment and issuance while posing valuation and financing risks.

Characteristics

General data

Inception date
11/10/2018
First Nav Date
24/09/2010
Currency
EUR
Show more
Valuation
Daily
Minimum initial investment
1 10/1000° share(s)/equity
Minimum additional investment
1 10/1000° share(s)/equity

Costs Composition

One-off costs upon entry or exit (Investment EUR 10,000)If you exit after 1 year
Entry costsThis includes distribution costs of 5.00% of amount invested. This is the most you will be charged. The person selling you the product will inform you of the actual charge.Up to €500.00
Exit costsWe do not charge an exit fee for this product, but the person selling you the product may do so.€0.00
Ongoing costs taken each year (Investment EUR 10,000)
Management fees and other administrative or operating costs2.10% of the value of your investment per year. This percentage is based on actual costs over the last year.€199.79
Transaction costs0.39% of the value of your investment per year. This is an estimate of the costs incurred when we buy and sell the underlying investments for the product. The actual amount will vary depending on how much we buy and sell.€37.23
Incidental costs taken under specific conditions (Investment EUR 10,000)
Performance fees

20.00% annual outperformance of the reference asset 100% MSCI EM (EMERGING MARKETS) NR Close. The calculation applies on each Net Asset Value calculation date in accordance with the terms described in the prospectus. Past underperformances over the last 5 years should be clawed back before any new accrual of performance fee.The actual amount will vary depending on how well your investment performs. The aggregated cost estimation above includes the average over the last 5 years.

The performance fee is paid even if the performance of the share over the performance observation period is negative, while remaining higher than the performance of the Reference Asset.

€0.00

Codification

ISIN code
LU1811398467
Bloomberg code
CPIGEAE LX
Reuters code

Investment Objective

“The fund invests in emerging market equities and seeks to outperform the MSCI Emerging Market index over the long term – at least 5 years. The final portfolio includes around a hundred emerging market stocks from all business sectors and with all sizes of market capitalisation. The investment process involves adapting the stock-picking method to market conditions.”
 

Documents

LanguageDocumentsTypeClosing Date
FI
PDF
01/09/2026
EN
PDF
31/07/2025
PDF
01/10/2026
PDF
31/01/2026
EN
PDF
26/10/2016
Prices expressed in a currency other than the base currency of the portfolio are available for information purposes only.
Nothing contained in this site constitutes a solicitation or offer by any member of the Amundi to provide any investment advice or service or to purchase or sell any financial instruments. The information it contains aims to inform the subscriber by providing information on the UCITS supplemental to that appearing in the Information Memorandum. The material provided on this site is presented as of the date shown and "as is". Amundi does not expressly or impliedly warrant the accuracy of the information provided on this site and expressly disclaims any warranties of fitness of this site for any particular purpose. This material reflects the opinion of the management company at the date of printing. The material is based upon information that we consider reliable, but we do not represent it is accurate, complete, valid or timely and it should not be relied on as such for any particular purpose. Any subscription should be based solely on the Information Memorandum provided to subscribers prior to the subscription and/or available upon request.

Institutional Sub-Class (Sub-Class I): Shares of this sub-class are only available to institutionals subscribing for their own account or within the framework of a collective savings or any comparable scheme, as well as UCITS. As such this Sub-Class benefits from the reduced "taxe d abonnement" of 0,01%. The minimum investment in this Sub-Class is USD 500,000.
Classic Sub-Class (Sub-Class C): Share of this sub-class are available to all investors. There is no minimum investment requirement in this sub-class.
Source : Amundi
© CPR Asset Management 2025
Legal notices Accessibility: non-compliant Cookies preferences